The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
36
0
0
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
5.6%
2 terminated/withdrawn out of 36 trials
84.6%
-1.9% vs industry average
28%
10 trials in Phase 3/4
0%
0 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (36)
Efficacy and Safety of Microtransplantation for Advanced and Relapsed Solid Tumors
Role: lead
Early Diagnosis of Pancreatic Cancer Via Deciphering Multi-modal Immunological Signatures
Role: collaborator
A Prospective, Open, Multicenter Clinical Trial of Eltrombopag Combined With Diacerein in Eltrombopag-inefficient or Relapsed ITP
Role: collaborator
Microtransplantation for Ovarian Cancer
Role: lead
Microtransplantation for Advanced and Relapsed Solid Tumors
Role: lead
Cord Blood Microtransplantation for Treatment of Acute Myeloid Leukemia
Role: lead
Allogeneic CART-19 for Elderly Relapsed/Refractory CD19+ ALL
Role: lead
CART-123 FOR Relapsed/Refractory Acute Myelocytic Leukemia（AML）
Role: lead
CART-19 FOR Relapsed/Refractory Acute Lymphoblastic Leukemia （ALL）
Role: lead
Exploratory Clinical Study of Apatinib and SHR-1210 in Treating Advanced Hepatocellular Carcinoma or Gastric Cancer
Role: lead
High Dose Donor Hematopoietic Stem Cell Infusion for Relapsed/Refractory AML
Role: lead
Individual Dosage Selection of Irinotecan (CPT-11) Based on UGT1A1 Genotype in Metastatic Colorectal Cancer Patients
Role: lead
A Study of Fluzoparib Given in Combination With Apatinib and Paclitaxel in Gastric Cancer Patients
Role: collaborator
A Prospective Multi-Center Research on Bowel Dysfunction After Sphincter Preservative Surgery
Role: collaborator
Apatinib as Maintenance Therapy After First Line Treatment in Locally Advanced or Metastatic Gastric Cancer
Role: lead
Microtransplantation With Decitabine and Cytarabine Improves Patient Outcomes in Myelodysplastic Syndromes
Role: lead
HLA-mismatched Microtransplantation for High Risk Acute Myeloid Leukemia
Role: lead
Safety and Efficacy Study of Microtransplantation to Treat Elderly Acute Myeloid Leukemia
Role: lead
Microtransplantation in Older Patients With Acute Myeloid Leukemia
Role: lead
Allogeneic CART-33 for Relapsed/Refractory CD33+ AML
Role: lead